2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Poster Session

[P65] Poster Session 65 Hematologic Malignancies 3

Takenori Takahata1, Takuto Tachita1, Satoru Yamashita1, Toru Ebina1, Kosuke Kamata1, Yu Chen2, Kensuke Saito2, Atsushi Sato2, Kazufumi Yamagata3, Yoshiko Tamai4, Shinsaku Fukuda1 (1.Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, 2.Department of Medical Oncology, Hirosaki University Graduate School of Medicine, 3.Department of Bioscience and Laboratory Medicine, Hirosaki University Graduate School of Health Sciences, 4.Department of Transfusion and Cell Therapy Medicine, Hirosaki University Graduate School of Medicine)

Tomotaka Suzuki1, Dai Maruyama2, Ryunosuke Machida3, Tomoko Kataoka3, Noriyasu Fukushima4, Nobuyuki Takayama5, Rie Ohba6, Ken Omachi7, Yoshitaka Imaizumi8, Masahito Tokunaga9, Hiroo Katsuya10, Isao Yoshida11, Kazutaka Sunami12, Mitsutoshi Kurosawa13, Nobuko Kubota14, Hiroaki Morimoto15, Miki Kobayashi16, Kazuhito Yamamoto17, Yoshihiro Kameoka18, Yoshitoyo Kagami19, Takayuki Tabayashi20, Masaki Maruta21, Tsutomu Kobayashi22, Shinsuke Iida23, Hirokazu Nagai24 (1.Department of Hematology and Oncology, Nagoya City University, 2.Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3.JCOG Data Center/Operations Office, National Cancer Center Hospital, 4.Department of Hematology and Oncology, Hiroshima University Research Institute for Radiation Biology and Medicine, 5.Department of Hematology, Kyorin University School of Medicine, 6.Department of Clinical Oncology and Hematology, The Jikei University Daisan Hospital, 7.Department of Hematology Oncology, Tokai University School of Medicine, 8.Department of Hematology, Nagasaki University Hospital, 9.Department of Hematology, Imamura General Hospital, 10.Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 11.Department of Hematologic Oncology, National Hospital Organization Shikoku Cancer Center, 12.Department of Hematology, National Hospital Organization Okayama Medical Center, 13.Department of Hematology, National Hospital Organization Hokkaido Cancer Center, 14.Department of Hematology, Saitama Cancer Center, 15.Department of Hematology, University of Occupational and Environmental Health, 16.Department of Hematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, 17.Department of Hematology and Cell Therapy, Aichi Cancer Center, 18.Department of Hematology Nephrology, and Rheumatology, Akita University Graduate School of Medicine, 19.Department of Hematology, Toyota Kosei Hospital, 20.Department of hematology, Saitama Medical Center, Saitama Medical University, 21.Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Hospital, 22.Department of Hematology and Oncology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 23.Department of Hematology and Oncology, Nagoya City University Hospital, 24.Department of Hematology, National Hospital Organization Nagoya Medical Center)

Shin Lee1, Kei Fujita1,2, Tsukasaki Hikaru2,3, Oiwa Kana2,4, Negoro Euju2, Hara Takeshi1, Tsurumi Hisashi1, Ueda Takanori2, Yamauchi Tkahiro2 (1.Department of Hematology, Matsunami General Hospital, 2.Department of Hematology and Oncology, University of Fukui, 3.Department of hematology, Fukui Red Cross Hospital, 4.Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Science)